↓ Skip to main content

SWOG S1400C (NCT02154490)—A Phase II Study of Palbociclib for Previously Treated Cell Cycle Gene Alteration–Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Substudy)

Overview of attention for article published in Journal of Thoracic Oncology, July 2019
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news
8 news outlets
twitter
1 X user

Citations

dimensions_citation
65 Dimensions

Readers on

mendeley
66 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
SWOG S1400C (NCT02154490)—A Phase II Study of Palbociclib for Previously Treated Cell Cycle Gene Alteration–Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Substudy)
Published in
Journal of Thoracic Oncology, July 2019
DOI 10.1016/j.jtho.2019.06.027
Pubmed ID
Authors

Martin J Edelman, Mary W Redman, Kathy S Albain, Eric C McGary, Noman M Rafique, Daniel Petro, Saiama N Waqar, Katherine Minichiello, Jieling Miao, Vassiliki A Papadimitrakopoulou, Karen Kelly, David R Gandara, Roy S Herbst

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 66 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 66 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 8 12%
Researcher 7 11%
Student > Doctoral Student 6 9%
Student > Ph. D. Student 5 8%
Professor 4 6%
Other 14 21%
Unknown 22 33%
Readers by discipline Count As %
Medicine and Dentistry 16 24%
Biochemistry, Genetics and Molecular Biology 9 14%
Agricultural and Biological Sciences 4 6%
Nursing and Health Professions 3 5%
Pharmacology, Toxicology and Pharmaceutical Science 3 5%
Other 5 8%
Unknown 26 39%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 61. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 December 2021.
All research outputs
#700,516
of 25,385,509 outputs
Outputs from Journal of Thoracic Oncology
#104
of 3,511 outputs
Outputs of similar age
#14,973
of 360,043 outputs
Outputs of similar age from Journal of Thoracic Oncology
#3
of 39 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,511 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.3. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 360,043 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 39 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.